Combination of palbociclib with adjuvant endocrine therapy for treatment of hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer...

por Al-Foheidi, Meteb H., Albeshri, Asem Mohammed, Moamenkahan, Safwan Noor, Abdullah, Abdulmajid Mohammed, Abualola, Muhannad Sadaqa, Alharbi, Muath Hamed, Refa, Ahmed A., Bayer, Ali M., Shaheen, Ahmed Y., Aga, Syed Sameer, Khan, Muhammad Anwar, Al-Mansour, Mubarak M., Ibrahim, Ezzeldin M.
Publicado 2022